Shervin Pishevar is a renowned entrepreneur in America. He has made significant steps since he migrated into the US from Iran. This is evident from the success of the companies he has worked with and co-founded. As an angel investor, he has to be constantly looking at the state of the US economy, tech innovations (where he has mainly invested), and globalization. The current state of the American economy might just be the one that triggered him to storm Twitter with 50 tweets in 21 hours in February 2018.
In one of his tweets, Shervin Pishevar gets nostalgic about a trip he had to Romania back in 2009. Basically, this is intended to show that there is a lot of talent out there that American entrepreneurs need to exploit. After all, there aren’t enough American-born engineers in the United States to supply the skill set needed in their companies. Shervin Pishevar tweets that “Wrote some of the seeds of this on a trip To Romania recruiting a young talented coder to SGN in 2009.” This tweet is followed by a picture of an essay which talks about the need for American entrepreneurs to reach out to the talent across the world. It is where the future lies.
Shervin Pishevar shows support for globalization. He is in line with the idea that the world has evolved, and knowledge is no longer defined by culture or geographical locations. Today, the world can be likened to a global village. America is no longer a monopoly when it comes to entrepreneurship. There are many people out there with skills as good, and even better than those thatAmerican entrepreneurs look for in their countrymen.
He notes in his essay that embracing talent from elsewhere is one of the best ways to learn. This is one of the best ways to build a great America, especially with the unpredictable and ever-changing financial markets. Evidently, Shervin’s word has come to be true 9 years down the line. He himself notes that “Now 9 years after that essay the world has evolved away & beyond us. And the chickens are coming home to roost.”
Not all companies out there are worth investing in and Sahm Adrangi is one of the top investors in the country today that is doing his duty to inform other investors and the general public of companies that are an issue. The latest company that has taken fire from Kerrisdale Capital, Sahm Adrangi’s investment company, is Proteostasis. This biotech firm has made claims recently that they have had great success developing a new drug for cystic fibrosis patients. So far, Proteostasis claims this drug will dramatically increase lung performance for patients.
In order to get to the bottom of whether or not these claims are good, Sahm Adrangi and Kerrisdale has done some digging into the biotech firm. Unfortunately, what Sahm has found is not so good for those who might be excited about this new drug. CFTR amplifier PTI-428 is what Proteostasis is calling their product, which Sahm is calling a drug cocktail. According to the report, Proteostasis only had four subjects for their testing, which means this was a very small scale test that cannot be accurately assessed based on the presented data. Not only is the data incomplete, but the results are messy and practically missing, which causes Sahm Adrangi to believe these statements are likely false or due to very poor testing procedures by the biotech company. The placebo test conducted found a drop in lung performance as well, meaning their statements that this drug can increase lung performance cannot be true.
Due to all of these concerns, Kerrisdale has taken the short position with Proteostasis. This means they will continue to profit as the stock value of Proteostasis drops, which it has already started doing since Kerrisdale’s negative report went public. This is mostly because of other investors that are keen to follow the advice of Sahm Adrangi, who happens to be a high-profile investor in the U.S. that regularly states his opinions on companies and calls them out for their shady practices. Sahm has an impressive track recordof success, couple that with hardly being wrong in his investments or arguments, most investors have started following in his footsteps.